| INTRODUC TI ON
The incidence of invasive fungal infections (IFIs) caused by uncommon Candida species with diverse virulence and susceptibility profiles has increased in recent years. 1, 2 In the Metschnikowiaceae clade,
Candida auris as an emerging fungus is associated with invasive infections, high mortality and multidrug-resistance. 3, 4 Since 2009, the infection has been reported worldwide from a multitude of clinical manifestations ie, colonisation, mucosal infections, deep-seated infections and candidaemia within a short period of time. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] This species exhibits a close phylogenetic relationship with Candida haemulonii and precise species identification is essential for the administration of proper antifungal therapy and the control of outbreaks in healthcare settings. 12, 16, 25 Accurate identification of C. auris is challenging, as conventional methods often misidentify it as other Candida species. 25, 26 In addition, the majority of isolates are resistant to fluconazole and show variable resistance to other antifungals, which has become a severe clinical challenge. 3 Because of the limited available treatment choices and high rate of therapeutic failures, novel alternative antifungal strategies including combination therapy are needed to improve patient outcomes. 27 The distant phylogenetic relationship between some isolates helps clarify some of their fluctuating characteristics ie antifungal resistance and degree of pathogenicity. In the invertebrate Galleria mellonella infection model, the aggregate-forming isolates exhibited significantly less pathogenicity than their non-aggregating counterparts and the nonaggregating isolates exhibited pathogenicity comparable to that of C. albicans. 28 Furthermore, the pathogenicity of C. auris and C. haemulonii, tested in an immunosuppressed mouse model of disseminated candidiasis, showed aggregate yeast cells with no pseudohyphae in mice infected with C. auris and C. haemulonii that was completely non-virulent in this model. 18 Owing to the difficulty in identifying C. auris isolates with traditional and molecular methods, the etiological agent was not identified or at least wrongly identified in many countries. Therefore, the real incidence of C. auris isolates in the clinical setting is unknown. Due to the scarce clinical and experimental data on the pathogenicity of C. auris, the aim of this study was to develop a murine model of invasive infection to evaluate and compare the virulence of the two clinically relevant species, C. auris and C. haemulonii with C. glabrata and C. albicans in an immunocompetent murine model of disseminated infection. 
| MATERIAL S AND ME THODS

| Fungal isolates
| Inoculum preparation
All isolates were cultured twice at 35°C for 48 hours on Sabouraud dextrose agar (SDA) supplemented with 0.02% chloramphenicol prior to in vivo used, to ensure viability and purity. For inoculum preparation, isolates were sub-cultured into brain heart infusion broth and allowed to grow overnight in a shaking incubator at 35°C.
After centrifugation, the supernatant was removed and the cells 
| Experimental disseminated infection
Experiments were carried out with three different inocula 1 × 10 5 , 1 × 10 6 and 1 × 10 7 CFU/mouse. Mice were inoculated by injecting 0.2 mL of the desired inoculum into the lateral tail vein. A control group received intravenous injection of cell-free phosphate-buffered saline (PBS) in exactly the same manner.
| Mortality study
For the survival study, we used 10 mice for each of three different inocula and control groups. Deaths were recorded through day 30
postinfection. Any animal that appeared moribund was humanely euthanised, with death recorded as occurring the next day. Animals surviving at the end of the experiment or moribund animals were euthanised by CO 2 anoxia.
| Fungal burden study
Five mice per isolate with three different inocula were sacrificed by cervical dislocation on experimental days 5 and 10 postinfection.
After sacrifice, kidneys, liver, spleen and lung of each mouse were immediately aseptically removed, weighed, and were homogenised in 1 mL of sterile saline solution. Homogenates were serially diluted (1:10) and aliquots of 0.1 mL of the undiluted and diluted homogenates were then plated in duplicate onto PDA agar plates to determine fungal load (CFU/g of tissue) after 48 hours of incubation at 37°C.
Five uninfected mice were used as controls per experimental day.
The entire in vivo experiments were performed twice at different times.
| Histopathology
After mice were sacrificed, kidney was fixed with 10% (wt./vol.) buffered formalin and then dehydrated, paraffin embedded, and sliced into 5 μm sections, which were then stained with Periodic acid-Schiff (PAS) for examination by light microscopy (DME; Leica Microsystems Inc., Buffalo, NY, USA). 
| Statistical analysis
| RE SULTS
High virulence was shown with C. albicans, C. auris, C. glabrata and C. haemulonii, respectively, since most of the isolates tested in the present study produced lethal infections in majority of mice ( Figure 1 ). Figure 1A shows that at a 1 × 10 5 CFU/mouse inoculum there were differences in survival rates between the different species 
| D ISCUSS I ON
Recently, many animal models have been developed for common pathogenic yeasts, which have been useful for evaluating antifungal therapies. 29, 30 Candida auris is a recently identified multidrug-resistant Candida species that has been associated with infection and outbreaks in healthcare settings in five continents. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] In the current report, we present a comparative study of the pathogenicity of two isolates of C. auris with
C. haemulonii, C. glabrata and C. albicans, showing that
C. auris virulence is comparable to that seen with C. albicans.
Disseminated infection by C. auris has been reported to involve multiple body sites, including blood, skin, urogenital tract and respiratory tract, pericarditis, and pneumonia. 31, 32 In our study, we recovered fungi from all organs, including kidneys without hyphae that has been described in two different models of C. auris infection 18, 28 and confirmed in our study. In contract, in G. mellonella that was significantly higher than that seen with most other common pathogenic yeast species, with overall pathogenicity approaching that observed with C. albicans and C. tropicalis isolates. 28 The ability of the fungus to survive, grow and evade the immune system in mammalian tissues seems to be a strain attribute that depends on the expression and regulation of various genes. In conclusion, no significant difference of survival rate was observed between C. auris and either C. albicans or 
